Well worth a watch- a lot of
confidence around the near term contracts with insurers and accountable care organisations. seems almost. retain they will sign up for trials. The trial sizes alone will boost revenue significantly.
He gives a good explanation of how the cost savings work for these organisations and the low target for readmission prevention that RSH needs to provide to meet the requirement for a
full contract to follow.
Ann: SouthWest Connect Conference, page-6
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.80M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400000 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 199999 | 1 |
View Market Depth
| Last trade - 16.12pm 04/07/2024 (20 minute delay) ? |
| RSH (ASX) Chart |
Day chart unavailable